A2M production by B-cells has not yet been studied, however autocrine IL‐6 production by CLL B-cells has been described (28), and was shown to be associated with poor clinical outcome in CLL (29) due to IL‐6‐mediated survival mechanisms that provide resistance of CLL cells to chemotherapy. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.